Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Follicular phenotype of hidradenitis suppurativa in down syndrome: A multicentre case-control study.
Follicular phenotype of hidradenitis suppurativa in down syndrome: A multicentre case-control study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 10, 2026
Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flares.
Journal: The Journal of clinical investigation
Published: July 01, 2025
The P2X7-NLRP3 inflammasome inhibitor AZD9056 has no significant effect on hidradenitis suppurativa clinical disease activity but restores cytokine production in peripheral blood mononuclear cells: Results of a phase 2 trial.
Journal: Journal of the American Academy of Dermatology
Published: May 20, 2025
Correction: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions.
Journal: Dermatology and therapy
Published: April 04, 2025
Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial.
Journal: The British journal of dermatology
Published: February 02, 2025
International survey on training of dermatology residents in supportive oncodermatology: the RESCUE study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: November 05, 2024
Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions.
Journal: Dermatology and therapy
Published: August 22, 2024
Radiation Recall Dermatitis With Bruton Tyrosine Kinase Inhibitor Therapy.
Journal: JAMA dermatology
Published: March 27, 2024
Risk of keratinocyte carcinomas following extracorporeal photopheresis among lung transplant recipients: A retrospective cohort study.
Journal: Journal of the American Academy of Dermatology
Published: June 26, 2023
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial.
Journal: Lancet (London, England)
Published: May 23, 2023
Development of the Generalized Pustular Psoriasis Clinical Assessment Tool.
Journal: Journal of the American Academy of Dermatology
Published: May 17, 2023
Last Updated: 09/26/2026